R.J. Knox

1.0k total citations
26 papers, 775 citations indexed

About

R.J. Knox is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, R.J. Knox has authored 26 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in R.J. Knox's work include DNA and Nucleic Acid Chemistry (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer Research and Treatments (4 papers). R.J. Knox is often cited by papers focused on DNA and Nucleic Acid Chemistry (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer Research and Treatments (4 papers). R.J. Knox collaborates with scholars based in United Kingdom, United States and Bulgaria. R.J. Knox's co-authors include John Bridgewater, Mary Collins, Caroline J. Springer, W.S. Zaugg, R.C. Knight, David Edwards, Nigel P. Minton, J. D. Pitts, Frank Friedlos and Roger G. Melton and has published in prestigious journals such as Journal of Molecular Biology, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

R.J. Knox

26 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.J. Knox United Kingdom 16 486 240 149 111 107 26 775
Emmanuele De Vendittis Italy 22 954 2.0× 105 0.4× 70 0.5× 105 0.9× 118 1.1× 57 1.3k
J. Wijdenes Netherlands 8 450 0.9× 29 0.1× 71 0.5× 75 0.7× 55 0.5× 13 653
Julia Walton United Kingdom 10 354 0.7× 290 1.2× 24 0.2× 147 1.3× 97 0.9× 21 651
Alessandro Pintar Italy 18 679 1.4× 93 0.4× 25 0.2× 80 0.7× 139 1.3× 39 1.0k
C. H. Robinson United States 17 452 0.9× 173 0.7× 30 0.2× 319 2.9× 26 0.2× 51 1.0k
Peter Kuhl Germany 20 792 1.6× 113 0.5× 72 0.5× 215 1.9× 121 1.1× 61 1.1k
Margret Ryan United States 15 545 1.1× 66 0.3× 46 0.3× 158 1.4× 63 0.6× 23 834
Siya Ram United States 15 387 0.8× 76 0.3× 14 0.1× 685 6.2× 117 1.1× 58 1.2k
N.D. Jones United States 10 363 0.7× 113 0.5× 31 0.2× 202 1.8× 56 0.5× 19 649
Robert G. Hughes United States 13 451 0.9× 24 0.1× 287 1.9× 455 4.1× 80 0.7× 26 998

Countries citing papers authored by R.J. Knox

Since Specialization
Citations

This map shows the geographic impact of R.J. Knox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.J. Knox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.J. Knox more than expected).

Fields of papers citing papers by R.J. Knox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.J. Knox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.J. Knox. The network helps show where R.J. Knox may publish in the future.

Co-authorship network of co-authors of R.J. Knox

This figure shows the co-authorship network connecting the top 25 collaborators of R.J. Knox. A scholar is included among the top collaborators of R.J. Knox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.J. Knox. R.J. Knox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Skelly, Jane V., R.J. Knox, & T.C. Jenkins. (2001). Aerobic Nitroreduction by Flavoproteins: Enzyme Structure, Mechanisms and Role in Cancer Chemotherapy. Mini-Reviews in Medicinal Chemistry. 1(3). 293–306. 15 indexed citations
3.
Anderson, David A., et al.. (1999). High-performance liquid chromatographic method for sensitive determination of the alkylating agent CB1954 in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 731(2). 293–298. 3 indexed citations
4.
Brown, John E., et al.. (1998). Preliminary investigation of Cyathostemma argenteum, a plant species used in traditional medicine for the treatment of breast cancer. Journal of Pharmacy and Pharmacology. 50(Supplement_9). 222–222. 4 indexed citations
5.
Wyatt, Michael D., et al.. (1997). Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9. British Journal of Cancer. 76(12). 1596–1603. 27 indexed citations
6.
Bridgewater, John, R.J. Knox, J. D. Pitts, Mary Collins, & Caroline J. Springer. (1997). The Bystander Effect of the Nitroreductase/CB 1954 Enzyme/Prodrug System Is Due to a Cell-Permeable Metabolite. Human Gene Therapy. 8(6). 709–717. 108 indexed citations
7.
Cui, Wei, M. Rufus Crompton, Graham Harold, et al.. (1997). Selective cell ablation in transgenic mice expressing E. coli nitroreductase. Gene Therapy. 4(2). 101–110. 57 indexed citations
8.
Knox, R.J., Steve Hobbs, T.C. Jenkins, et al.. (1996). Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy.. PubMed. 3(12). 1143–50. 35 indexed citations
9.
Bridgewater, John, et al.. (1995). Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. European Journal of Cancer. 31(13-14). 2362–2370. 156 indexed citations
10.
Duncan, Ruth, et al.. (1995). The chemotherapy of colon cancer. European Journal of Cancer. 31(7-8). 1373–1378. 19 indexed citations
11.
Anlezark, Gill, Roger G. Melton, Roger F. Sherwood, et al.. (1995). Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase. Biochemical Pharmacology. 50(5). 609–618. 73 indexed citations
12.
Chen, Shiuan, R.J. Knox, Frank Friedlos, et al.. (1995). Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.. Molecular Pharmacology. 47(5). 934–939. 51 indexed citations
13.
Skelly, Jane V., R.J. Knox, Elspeth F. Garman, et al.. (1989). Preliminary crystallographic data for NAD(P)H quinone reductase isolated from the Walker 256 rat carcinoma cell line. Journal of Molecular Biology. 205(3). 623–624. 4 indexed citations
14.
Knox, R.J., David Lydall, Frank Friedlos, Connie Basham, & J. J. Roberts. (1987). The effect of monofunctional or difunctional platinum adducts and of various other associated DNA damage on the expression of transfected DNA in mammalian cell lines sensitive or resistant to difunctional agents. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 908(3). 214–223. 24 indexed citations
15.
Knox, R.J., David Edwards, & R.C. Knight. (1984). The mechanism of nitroimidazole damage to DNA: Coulometric evidence. International Journal of Radiation Oncology*Biology*Physics. 10(8). 1315–1318. 20 indexed citations
16.
Edwards, David, et al.. (1984). Photosensitive interaction of RSU 1069 with DNA. International Journal of Radiation Oncology*Biology*Physics. 10(8). 1319–1322. 5 indexed citations
17.
Knox, R.J., R.C. Knight, & D.I. Edwards. (1980). Mechanism of action of misonidazole. 8(3). 190. 3 indexed citations
18.
Zaugg, W.S. & R.J. Knox. (1966). Indirect Determination of Inorganic Phosphate by Atomic Absorption Spectrophotometric Determination of Molybdenum.. Analytical Chemistry. 38(12). 1759–1760. 50 indexed citations
19.
Knox, R.J., et al.. (1958). The relationship between airborne bacteria and organisms recovered from children in a burns unit.. PubMed. 107(2). 69–85. 3 indexed citations
20.
Knox, R.J., K.S. Maclean, & J. M. Robson. (1952). New Results with Isonicotinic Acid Hydrazide. BMJ. 1(4767). 1081–1081. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026